NM_001172509.2:c.1173+5A>G

Variant names:

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001172509.2(SATB2):c.1173+5A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000408 in 1,566,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)

Exomes 𝑓: 0.000035 ( 0 hom. )

Consequence

SATB2
NM_001172509.2 splice_region, intron

Scores

Splicing: ADA: 0.0002538

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.690

Publications

0 publications found

Variant links:

Genes affected

SATB2 (HGNC:21637): (SATB homeobox 2) This gene encodes a DNA binding protein that specifically binds nuclear matrix attachment regions. The encoded protein is involved in transcription regulation and chromatin remodeling. Defects in this gene are associated with isolated cleft palate and cognitive disability. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Feb 2010]

SATB2 Gene-Disease associations (from GenCC):

chromosome 2q32-q33 deletion syndrome
Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
SATB2 associated disorder
Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen

SATB2 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.74).

BP6

Variant 2-199348696-T-C is Benign according to our data. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-199348696-T-C is described in CliVar as Likely_benign. Clinvar id is 568908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BS1

Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000985 (15/152226) while in subpopulation NFE AF = 0.00022 (15/68040). AF 95% confidence interval is 0.000135. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

BS2

High AC in GnomAd4 at 15 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
SATB2	NM_001172509.2 link	c.1173+5A>G		splice_region_variant, intron_variant	Intron 7 of 10	ENST00000417098.6	NP_001165980.1	Q9UPW6-1A0A024R3U6B3KPQ9

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
SATB2	ENST00000417098.6 link	c.1173+5A>G		splice_region_variant, intron_variant	Intron 7 of 10	2	NM_001172509.2	ENSP00000401112.1		Q9UPW6-1

Frequencies

GnomAD3 genomes

AF:

0.0000985

AC:

AN:

152226

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.000220

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000140

AC:

AN:

214834

AF XY:

0.00000878

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000302

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000346

AC:

AN:

1414750

Hom.:

Cov.:

AF XY:

0.0000300

AC XY:

AN XY:

699914

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

32306

American (AMR)

AF:

0.0000249

AC:

AN:

40218

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

22642

East Asian (EAS)

AF:

0.00

AC:

AN:

39460

South Asian (SAS)

AF:

0.00

AC:

AN:

77114

European-Finnish (FIN)

AF:

0.00

AC:

AN:

51418

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5492

European-Non Finnish (NFE)

AF:

0.0000423

AC:

AN:

1087710

Other (OTH)

AF:

0.0000343

AC:

AN:

58390

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.521

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000985

AC:

AN:

152226

Hom.:

Cov.:

AF XY:

0.000121

AC XY:

AN XY:

74364

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41466

American (AMR)

AF:

0.00

AC:

AN:

15278

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.00

AC:

AN:

5196

South Asian (SAS)

AF:

0.00

AC:

AN:

4836

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10622

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.000220

AC:

AN:

68040

Other (OTH)

AF:

0.00

AC:

AN:

2090

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.542

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.0000605

Hom.:

Bravo

AF:

0.0000378

ClinVar

Significance: Likely benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Benign:1

Sep 01, 2023

CeGaT Center for Human Genetics Tuebingen

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

SATB2: BP4 -

Chromosome 2q32-q33 deletion syndrome

Benign:1

Feb 01, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.74

CADD

Benign

8.3

(source)

DANN

Benign

0.67

PhyloP100

-0.69

Mutation Taster

=97/3

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

dbscSNV1_ADA

Benign

0.00025

dbscSNV1_RF

Benign

0.086

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over